Paul E. Sax
Highly rated in
Highly rated in
Check Dr. Paul E. Sax's experience treating your condition:
About Dr. Paul E. Sax

Paul Sax is an Infectious Disease expert in Boston, Massachusetts. Sax has been practicing medicine for over 36 years and is highly rated in 9 conditions, according to our data. His top areas of expertise are HIV/AIDS, AIDS Dysmorphic Syndrome, Myelitis, and AIDS Dementia Complex. He is licensed to treat patients in Massachusetts. Sax is currently accepting new patients.

His clinical research consists of co-authoring 208 peer reviewed articles and participating in 11 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Paul E. Sax it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Paul E. Sax accepts the following insurance:

  •  Ambetter
  •  Anthem

Call to see if your plan is accepted.
75 Francis St, Boston, MA 02115
Background & Education
Graduate Institution
Harvard Medical School, 1987
Infectious Disease
Internal Medicine in MA
Hospital Affiliations
Massachusetts General Hospital
Brigham And Womens Hospital
Brigham And Womens Faulkner Hospital
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Doravirine for Persons With Excessive Weight Gain on Integrase Inhibitors and Tenofovir Alafenamide (The Do IT Study)
Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)
Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of HIV-1 Persistence and on HIV-1-Specific Immune Responses
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure (ASPIRE) Study
A Study to Evaluate Dolutegravir Plus Lamivudine Dual Therapy for the Treatment of Naïve HIV-1-infected Participants
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)
View 10 Less Clinical Trials -

208 Total Publications

Reply to Authors.

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors